Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)

NCT05321875 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Cardiomyopathy, Dilated

Interventions

DRUG: Candesartan

Sponsor

Cristina Avendaño Solá